MARKET

ASMB

ASMB

Assembly Bioscie
NASDAQ
26.64
-1.06
-3.83%
After Hours: 26.64 0 0.00% 16:10 03/30 EDT
OPEN
27.84
PREV CLOSE
27.70
HIGH
28.12
LOW
26.32
VOLUME
72.60K
TURNOVER
--
52 WEEK HIGH
39.71
52 WEEK LOW
7.75
MARKET CAP
422.58M
P/E (TTM)
-48.7823
1D
5D
1M
3M
1Y
5Y
1D
Assembly Biosciences Adopts 2026 Performance-Based Bonus Plan
TipRanks · 8h ago
Assembly Biosciences boosts CEO Okazaki bonus target to 65% under new cash plan
Reuters · 10h ago
Weekly Report: what happened at ASMB last week (0323-0327)?
Weekly Report · 23h ago
HC Wainwright & Co. Reiterates Buy on Assembly Biosciences, Maintains $50 Price Target
Benzinga · 4d ago
Assembly Biosciences Price Target Maintained With a $50.00/Share by HC Wainwright & Co.
Dow Jones · 4d ago
Analysts’ Top Healthcare Picks: COMPASS Pathways (CMPS), Assembly Biosciences (ASMB)
TipRanks · 6d ago
Assembly Biosciences Advances HSV-2 Drug ABI-1179 With Completion of Early-Stage Trial
TipRanks · 03/23 16:30
Weekly Report: what happened at ASMB last week (0316-0320)?
Weekly Report · 03/23 09:22
More
About ASMB
Assembly Biosciences, Inc. is a biotechnology company, which is engaged in the development of small-molecule therapeutics designed to change the path of serious viral diseases and improve the lives of patients worldwide. Its pipeline includes multiple clinical-stage investigational therapies, including two helicase-primase inhibitors (HPI) targeting recurrent genital herpes; an orally bioavailable hepatitis delta virus (HDV) entry inhibitor, and a potent next-generation capsid assembly modulator (CAM) designed to disrupt the replication cycle of hepatitis B virus (HBV) at several key points. Its pipeline also includes a novel, oral broad-spectrum non-nucleoside polymerase inhibitor (NNPI) targeting transplant-related herpesviruses, which is undergoing studies to enable a regulatory filing, and it also has additional research programs against multiple antiviral targets. It is advancing two investigational long-acting HPI candidates, ABI-5366 (5366) and (2) ABI-1179 (1179).

Webull offers Assembly Biosciences Inc stock information, including NASDAQ: ASMB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ASMB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ASMB stock methods without spending real money on the virtual paper trading platform.